Pitavastatin and Ultracet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 5 people who take Pitavastatin and Ultracet. Common interactions include surgery among females, and sinusitis among males.
The phase IV clinical study analyzes what interactions people who take Pitavastatin and Ultracet have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
5 people who take Pitavastatin and Ultracet together, and have interactions are studied.
What is Pitavastatin?
Pitavastatin has active ingredients of pitavastatin. Currently, eHealthMe is studying from 1,569 Pitavastatin users.
What is Ultracet?
Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is used in pain. Currently, eHealthMe is studying from 6,213 Ultracet users.
Number of Pitavastatin and Ultracet reports submitted per year:

Common Pitavastatin and Ultracet drug interactions by gender *:
female:
- Surgery
- Cerebrospinal fluid leakage
- Diabetes mellitus
- Meningitis
- Compression fracture
- Fall
- Femur fracture
- Spondylolisthesis
male:
- Sinusitis
- Vision blurred
- Emphysema
Common Pitavastatin and Ultracet drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Vision blurred
- Cerebrospinal fluid leakage
- Diabetes mellitus
- Meningitis
- Sinusitis
60+:
- Compression fracture
- Fall
- Femur fracture
- Spondylolisthesis
- Surgery
- Emphysema
* Approximation only. Some reports may have incomplete information.
Do you take Pitavastatin and Ultracet?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Pitavastatin side effects (1,569 reports)
- Ultracet side effects (6,213 reports)
Common Pitavastatin drug interactions:
- Pitavastatin and Amlodipine: 225 reports
- Pitavastatin and Aspirin: 195 reports
- Pitavastatin and Metformin: 174 reports
- Pitavastatin and Ezetimibe: 167 reports
- Pitavastatin and Clopidogrel: 138 reports
- Pitavastatin and Lansoprazole: 133 reports
- Pitavastatin and Acetaminophen: 132 reports
- Pitavastatin and Furosemide: 129 reports
- Pitavastatin and Sertraline: 127 reports
- Pitavastatin and Bisoprolol fumarate: 116 reports
Browse interactions between Pitavastatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ultracet drug interactions:
- Ultracet and Prednisone: 674 reports
- Ultracet and Aspirin: 563 reports
- Ultracet and Neurontin: 533 reports
- Ultracet and Methotrexate: 531 reports
- Ultracet and Humira: 475 reports
- Ultracet and Nexium: 463 reports
- Ultracet and Tramadol: 462 reports
- Ultracet and Celebrex: 453 reports
- Ultracet and Vioxx: 440 reports
- Ultracet and Lipitor: 430 reports
Browse interactions between Ultracet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pitavastatin and acetaminophen; tramadol hydrochloride (the active ingredients of Pitavastatin and Ultracet, respectively), and Pitavastatin and Ultracet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pitavastatin and Ultracet.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydroxyurea and Cardio-Respiratory Arrest - a second ago
- Lisinopril And Hydrochlorothiazide and Death - 13 seconds ago
- Byetta and Atelectasis - 19 seconds ago
- Voltaren and Blood Glucose Fluctuation - 20 seconds ago
- Requip and Face Injury - 20 seconds ago
- Pantoprazole and Temovate drug interaction - 21 seconds ago
- Guaifenesin and Uveitis - 22 seconds ago
- Imbruvica and Herpes Zoster - 25 seconds ago
- Miralax and Aripiprazole drug interaction - 31 seconds ago
- Januvia and Immunosuppressant Drug Level Increased - 43 seconds ago